Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 10, 2026 · most recent call
HIMS’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Hims & Hers Health, Inc.’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: HIMS daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
No 8-K events recorded since this call day.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $481M | +95.1% | $0.11 | — | 3.9% | 5.4% | $60M |
| FY2025 Q1 | $586M | +110.7% | $0.20 | +300.0% | 9.9% | 8.4% | $50M |
| FY2025 Q2 | $545M | +72.6% | $0.17 | +200.4% | 4.9% | 7.8% | $-69M |
| FY2025 Q3 | $599M | +49.2% | $0.06 | -80.2% | 2.0% | 2.6% | $91M |
| FY2025 Q4 | $618M | +28.4% | $0.08 | -27.3% | 1.5% | 3.3% | $821,000 |
| FY2026 Q1 | $608M | +3.8% | $-0.40 | -300.0% | -2.7% | -15.1% | $53M |
| FY2026 Q2Selected | $753M | +38.2% | $-0.37 | -317.6% | -12.9% | -11.5% | $-55M |
Management-stated figures from HIMS’s newest call are part of Tellvest Pro.